TheraDerm-LRS tes-tosterone patch data

THRT (Salt Lake City) completed Phase III testing in 120 hypogonadal men, aged 15 to 65, and interim analysis shows that the "great majority" of the 90 men who got the patch maintained physiologically normal levels of tes-tosterone.

Data collected on cholesterol levels and on the prostate gland show the product is safe to use. The men were treated with the patch for six to 12 months, with the patch applied at night. ...